Latest News
Pioneer Group reinvests in the Nottingham-based company to help accelerate its first two products - designed to aid the healing ...
Sygnature Discovery, the global integrated drug discovery company, has unveiled a new platform that facilitates the combinational high-throughput assembly and ...
Harry Pickering, Pioneer Group's Portfolio Director & Head of UK Investment, joined our team six months ago. Formerly, Harry was ...
MIP Discovery, a leader in the field of Molecularly Imprinted Polymers (MIPs) based at our Colworth Science Park location, has ...
Pioneer Group's Accelerator Programme allows our experts to identify the potential of innovative entrepreneurial life sciences ventures at an early ...
Today we are proud to announce our lead investment in Selentus Science, a surgical innovator, to support the development of ...
Event has been set up to mark the 13th anniversary of Ada Lovelace Day and is the largest-of-its-kind in the ...
AbbVie And Pioneer Group Name NanoSyrinx As The Winner Of The 2022 AbbVie UK Golden Ticket Programme
NanoSyrinx is developing technology that aims to help medicines better target diseased cells by delivering therapeutic proteins directly to the ...
Combination creates global leader in process development and GMP manufacturing of advanced cell and gene therapies with transatlantic footprint in ...
